Marwa Mamdouh Shaaban

Dr. Marwa Mamdouh Shaaban

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Life
Verified
Journal Article
Open access
PDF file
JAJehan y Al-Humaidi
Jehan y Al-Humaidi
MSMarwa Mamdouh Shaaban
Marwa Mamdouh Shaaban
NRNadjet Rezki
Nadjet Rezki
ARAaouad Mohamed Reda
Aaouad Mohamed Reda
MZMohamed Zakaria
Mohamed Zakaria
Bassma ElwakilBassma Elwakil
Bassma Elwakil
SARS-CoV-2 and its variants, especially the Omicron variant, remain a great threat to human health. The need to discover potent compounds that may control the SARS-CoV-2 virus pandemic and the emerged mutants is rising. A set of 1,2,3-triazole and/or 1,2,4-triazole was synthesized either from benzimidazole or isatin precursors. Molecular docking studies and in vitro enzyme activity revealed that most of the investigated compounds demonstrated promising binding scores against the SARS-CoV-2 and Omicron spike proteins, in comparison to the reference drugs. In particular, compound 9 has the highest scoring affinity against the SARS-CoV-2 and Omicron spike proteins in vitro with its IC50 reaching 75.98 nM against the Omicron spike protein and 74.51 nM against the SARS-CoV-2 spike protein. The possible interaction between the synthesized triazoles and the viral spike proteins was by the prevention of the viral entry into the host cells, which led to a reduction in viral reproduction and infection. A cytopathic inhibition assay in the human airway epithelial cell line (Vero E6) infected with SARS-CoV-2 revealed the effectiveness and safety of the synthesized compound (compound 9) (EC50 and CC50 reached 80.4 and 1028.28 µg/mL, respectively, with a selectivity index of 12.78). Moreover, the antiinflammatory effect of the tested compound may pave the way to reduce the reported SARS-CoV-2-induced hyperinflammation.

1 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
NENeveen Mohamed Elleboudy
Neveen Mohamed Elleboudy
Bassma ElwakilBassma Elwakil
Bassma Elwakil
MSMarwa Mamdouh Shaaban
Marwa Mamdouh Shaaban
ZOZakia A. Olama
Zakia A. Olama
Despite recent scientific advances, the global load of bacterial disease remains high and has been established against a backdrop of increasing antimicrobial resistance. Therefore, there is a pressing need for highly effective and natural antibacterial agents. In the present work, the antibiofilm effect provided by essential oils was evaluated. Of these, cinnamon oil extract showed potent antibacterial and antibiofilm activities against Staphylococcus aureus at an MBEC of 75.0 µg/mL. It was revealed that benzyl alcohol, 2-propenal-3-phenyl, hexadecenoic acid, and oleic acid were the major components of the tested cinnamon oil extract. In addition, the interaction between the cinnamon oil and colistin showed a synergistic effect against S. aureus. Cinnamon oil that had been combined with colistin was encapsulated by liposomes to enhance the essential oil’s chemical stability, demonstrating a particle size of 91.67 nm, a PDI of 0.143, a zeta potential of −0.129 mV, and an MBEC of 50.0 µg/mL against Staphylococcus aureus. Scanning electron microscopy was employed to observe the morphological changes in the Staphylococcus aureus biofilm that was treated with the encapsulated cinnamon oil extract/colistin. As a natural and safe option, cinnamon oil exhibited satisfactory antibacterial and antibiofilm performance. The application of liposomes further improved the stability of the antibacterial agents and extended the essential oil release profile.

9 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
BFBalqis A. Fadel Fadel
Balqis A. Fadel Fadel
Bassma ElwakilBassma Elwakil
Bassma Elwakil
EFEsraa E. Fawzy
Esraa E. Fawzy
MSMarwa Mamdouh Shaaban
Marwa Mamdouh Shaaban
ZOZakia A. Olama
Zakia A. Olama
Hospitalized patients are severely impacted by delayed wound healing. Recently, there has been a growing focus on enhancing wound healing using suitable dressings. Lavandula angustifolia essential oil (LEO) showed potential antibacterial, anti-inflammatory, and wound healing properties. However, the prepared gold nanoparticles possessed multifunctional properties. Consequently, the present investigation aimed to synthesize a novel nanosystem consisting of nano-Lavandula angustifolia essential oil and gold nanoparticles prepared through ultrasonic nanoemulsifying techniques in order to promote wound healing and combat bacterial infection. LEO showed potent antibacterial activity against Klebsiella pneumoniae, MRSA and Staphylococcus aureus with minimum inhibitory concentration (MIC) values of 32, 16 and 16 µg/mL, respectively, while exhibiting low activity against Proteus mirabilis. Interestingly, the newly formulated nano-gold/nano-Lavandula angustifolia penetrated the preformed P. mirabilis biofilm with a full eradication of the microbial cells, with MIC and MBEC (minimal biofilm eradication concentration) values reaching 8 and 16 µg/mL, respectively. The cytotoxic effect of the novel nanoformula was also assessed against WI-38 fibroblasts vero (normal) cells (IC50 = 0.089 mg/mL) while nano-gold and nano-Lavandula angustifolia showed higher results (IC50 = 0.529, and 0.209 mg/mL, respectively). Nano-gold/nano-Lavandula angustifolia formula possessed a powerful wound healing efficacy with a 96.78% wound closure. These findings revealed that nano-gold/nano-Lavandula angustifolia nanoemulsion can inhibit bacterial growth and accelerate the wound healing rate.

1 February 2021 in Future Virology
Verified
Journal Article
Open access
Bassma ElwakilBassma Elwakil
Bassma Elwakil
MSMarwa Mamdouh Shaaban
Marwa Mamdouh Shaaban
Alaa El-Din BekhitAlaa El-Din Bekhit
Alaa El-Din Bekhit
MEMoustafa Y El-Naggar
Moustafa Y El-Naggar
ZOZakia A Olama
Zakia A Olama
Aim: To investigate the prospective anti COVID-19 activity of Egyptian propolis. Material & methods: Propolis samples were collected from different Egyptian geographical areas and characterized usi...

11 September 2021 in Chemometrics and Intelligent Laboratory Systems
Verified
Journal Article
Closed access
AAAbdullah Y. Alzahrani
Abdullah Y. Alzahrani
MSMarwa Mamdouh Shaaban
Marwa Mamdouh Shaaban
BEBassma H. Elwakil
Bassma H. Elwakil
MHMoaaz T. Hamed
Moaaz T. Hamed
NRNadjet Rezki
Nadjet Rezki
MHMohamed Hagar
Mohamed Hagar

7 July 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
FFaizah Aljohani
Faizah Aljohani
NRNadjet Rezki
Nadjet Rezki
ARAaouad Mohamed Reda
Aaouad Mohamed Reda
Mohamed E HagarMohamed E Hagar
Mohamed E Hagar
BKBassant Kamal
Bassant Kamal
Bassma ElwakilBassma Elwakil
Bassma Elwakil
Bacterial pneumonia is considered one of the most virulent diseases with high morbidity and mortality rates, especially in hospitalized patients. Moreover, bacterial resistance increased over the last decades which limited the therapy options to carbapenem antibiotics. Hence, the metallo-β-lactamase-producing bacteria were deliberated as the most deadly and ferocious infectious agents. Sulphadiazine-ZnO hybrids biological activity was explored in vitro and in vivo against metallo-β-lactamases (MBLs) producing Klebsiella pneumoniae. Docking studies against NDM-1 and IMP-1 MBLs revealed the superior activity of the 3a compound in inhibiting both MBLs enzymes in a valid reliable docking approach. The MBLs inhibition enzyme assay revealed the remarkable sulphadiazine-ZnO hybrids inhibitory effect against NDM-1 and IMP-1 MBLs. The tested compounds inhibited the enzymes both competitively and noncompetitively. Compound 3b-ZnO showed the highest antibacterial activity against the tested metallo-β-lactamase producers with an inhibition zone (IZ) diameter reaching 43 mm and a minimum inhibitory concentration (MIC) reaching 2 µg/mL. Sulphadiazine-ZnO hybrids were tested for their in vitro cytotoxicity in a normal lung cell line (BEAS-2Bs cell line). Higher cell viability was observed with 3b-ZnO. Biodistribution of the sulphadiazine-ZnO hybrids in the lungs of uninfected rats revealed that both [124I]3a-ZnO and [124I]3b-ZnO hybrids remained detectable within the rats’ lungs after 24 h of endotracheal aerosolization. Moreover, the residence duration in the lungs of [124I]3b-ZnO (t1/2 4.91 h) was 85.3%. The histopathological investigations confirmed that compound 3b-ZnO has significant activity in controlling bacterial pneumonia infection in rats.